Wound dressings - a review.
Selvaraj Dhivya, Viswanadha Vijaya Padma, Elango Santhini
https://pubmed.ncbi.nlm.nih.gov/26615539/Actively Recruiting
Led by Sohag University · Updated on 2025-08-27
20
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the use of tilapia fish skin as a healing dressing for patients with second or third-degree burns. This study aims to compare the clinical outcomes of burn wounds treated with tilapia fish skin dressing versus regular dressing. The goal is to understand how well the tilapia fish skin dressing supports wound healing compared to standard care methods. Participants will be randomly assigned to one of two groups one group will receive burn dressing using tilapia fish skin, while the other group will receive regular dressing. Both treatments are applied as procedures to the burn wounds. The study does not involve any blinding, and both treatments are actively compared to assess their effects. During the study, researchers will monitor wound healing progress, focusing on the effect of the dressings three weeks after regular dressing application. Participants will undergo regular assessments to evaluate wound healing and clinical outcomes. The total study duration extends until January 2026, allowing sufficient time for follow-up and observation of healing results.
CONDITIONS
Comparison Between Burn Dressing Using Tilapia-Fish Skin Versus Regular Dressing
O
Osama M Mohamed, Resident
G
Gamal Y Elsayed, Professor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Sohag University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 3 weeks
Participants receive burn dressing using either Tilapia-Fish Skin or regular dressing to promote wound healing.
Multiple visits for dressing changes and assessments during the 3-week period
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Selvaraj Dhivya, Viswanadha Vijaya Padma, Elango Santhini
https://pubmed.ncbi.nlm.nih.gov/26615539/Zhang Hu, Ping Yang, Chunxia Zhou...
https://pubmed.ncbi.nlm.nih.gov/28358307/Ahmed Ibrahim, Mahmoud Soliman, Saber Kotb...
https://pubmed.ncbi.nlm.nih.gov/33272259/Sohag University
Lead Sponsor